• 1
    Scales CD, Smith AC, Hanley JM, Saigal CS. Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012 Jul; 62(1):1605.
  • 2
    Monico CG, Milliner DS. Genetic determinants of urolithiasis. Nat Rev Nephrol. 2012 Mar; 8(3):15162.
  • 3
    Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005 Oct 1; 115(10):2598608.
  • 4
    Wright CA, Howles S, Trudgian DC, Kessler BM, Reynard JM, Noble JG, Hamdy FC, Turney BW. Label-free quantitative proteomics reveals differentially regulated proteins influencing urolithiasis. Mol Cell Proteomics. 2011 Aug; 10(8):M110.005686.
  • 5
    Chutipongtanate S, Nakagawa Y, Sritippayawan S, Pittayamateekul J, Parichatikanond P, Westley BR, May FE, Malasit P, Thongboonkerd V. Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor. J Clin Invest. 2005 Dec; 115(12):361322.
  • 6
    Lauderdale DS, Thisted RA, Wen M, Favus MJ. Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res. 2001 Oct; 16(10):18938.
  • 7
    Obligado SH, Goldfarb DS. The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens. 2008 Mar; 21(3):25764.
  • 8
    Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005 Sep; 68(3):12305.
  • 9
    Powell CR, Stoller ML, Schwartz BF, Kane C, Gentle DL, Bruce JE, Leslie SW. Impact of body weight on urinary electrolytes in urinary stone formers. Urology. 2000 Jun; 55(6):82530.
  • 10
    Kerstetter J, Caballero B, O'Brien K, Wurtman R, Allen L. Mineral homeostasis in obesity: effects of euglycemic hyperinsulinemia. Metab Clin Exp. 1991 Jul; 40(7):70713.
  • 11
    Whincup PH, Kaye SJ, Owen CG, Huxley R, Cook DG, Anazawa S, Barrett-Connor E, Bhargava SK, Birgisdottir BE, Carlsson S, de Rooij SR, Dyck RF, Eriksson JG, Falkner B, Fall C, Forsén T, Grill V, Gudnason V, Hulman S, Hyppönen E, Jeffreys M, Lawlor DA, Leon DA, Minami J, Mishra G, Osmond C, Power C, Rich-Edwards JW, Roseboom TJ, Sachdev HS, Syddall H, Thorsdottir I, Vanhala M, Wadsworth M, Yarbrough DE. Birth weight and risk of type 2 diabetes: a systematic review. JAMA. 2008 Dec 24; 300(24):288697.
  • 12
    Huxley RR, Shiell AW, Law CM. The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systematic review of the literature. J Hypertens. 2000 Jul; 18(7):81531.
  • 13
    Silveira VMFD, Horta BL. Birth weight and metabolic syndrome in adults: meta-analysis. Rev Saude Publica. 2008 Feb; 42(1):108.
  • 14
    Baird J, Kurshid MA, Kim M, Harvey N, Dennison E, Cooper C. Does birthweight predict bone mass in adulthood? A systematic review and meta-analysis. Osteoporos Int. 2011 May; 22(5):132334.
  • 15
    Forsén T, Eriksson JG, Tuomilehto J, Osmond C, Barker DJ. Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ. 1999 Nov 27; 319(7222):14037.
  • 16
    Harris A, Seckl J. Glucocorticoids, prenatal stress and the programming of disease. Horm Behav. 2011 Mar; 59(3):27989.
  • 17
    de Vries A, Holmes MC, Heijnis A, Seier JV, Heerden J, Louw J, Wolfe-Coote S, Meaney MJ, Levitt NS, Seckl JR. Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function. J Clin Invest. 2007 Apr; 117(4):105867.
  • 18
    Newnham JP, Moss TJ. Antenatal glucocorticoids and growth: single versus multiple doses in animal and human studies. Semin Neonatol. 2001 Aug; 6(4):28592.
  • 19
    Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev. 1979 Mar; 3(1):7983.
  • 20
    O'Connor TG, Ben-Shlomo Y, Heron J, Golding J, Adams D, Glover V. Prenatal anxiety predicts individual differences in cortisol in pre-adolescent children. Biol Psychiatry. 2005 Aug 1; 58(3):2117.
  • 21
    Gutteling BM, de Weerth C, Buitelaar JK. Prenatal stress and children's cortisol reaction to the first day of school. Psychoneuroendocrinology. 2005 Jul; 30(6):5419.
  • 22
    Huizink AC, Bartels M, Rose RJ, Pulkkinen L, Eriksson CJP, Kaprio J. Chernobyl exposure as stressor during pregnancy and hormone levels in adolescent offspring. J Epidemiol Community Health. 2008 Apr; 62(4):e5.
  • 23
    Edwards CR, Benediktsson R, Lindsay RS, Seckl JR. Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension?. Lancet. 1993 Feb 6; 341(8841):3557.
  • 24
    Phillips DI, Barker DJ, Fall CH, Seckl JR, Whorwood CB, Wood PJ, Walker BR. Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome?. J Clin Endocrinol Metab. 1998 Mar; 83(3):75760.
  • 25
    Reynolds RM, Walker BR, Phillips DI, Dennison EM, Fraser R, Mackenzie SM, Davies E, Connell JM. Programming of hypertension: associations of plasma aldosterone in adult men and women with birthweight, cortisol, and blood pressure. Hypertension. 2009 Jun; 53(6):9326.
  • 26
    Ishimoto H, Jaffe RB. Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit. Endocr Rev. 2011 Jun; 32(3):31755.
  • 27
    Chang HY, Hsu CH, Tsai JD, Li ST, Hung HY, Kao HA, Chang JH, Chung HY, Wang HK. Renal calcification in very low birth weight infants. Pediatr Neonatol. 2011 Jun; 52(3):1459.
  • 28
    Ashton N, Al-Wasil SH, Bond H, Berry JL, Denton J, Freemont AJ. The effect of a low-protein diet in pregnancy on offspring renal calcium handling. Am J Physiol Regul Integr Comp Physiol. 2007 Aug; 293(2):R75965.
  • 29
    Runyan AL, Chhokar VS, Sun Y, Bhattacharya SK, Runyan JW, Weber KT. Bone loss in rats with aldosteronism. Am J Med Sci. 2005 Jul; 330(1):17.
  • 30
    Cappuccio FP, Markandu ND, MacGregor GA. Renal handling of calcium and phosphate during mineralocorticoid administration in normal subjects. Nephron. 1988; 48(4):2803.
  • 31
    Gandhi MS, Deshmukh PA, Kamalov G, Zhao T, Zhao W, Whaley JT, Tichy JR, Bhattacharya SK, Ahokas RA, Sun Y, Gerling IC, Weber KT. Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism. J Cardiovasc Pharmacol. 2008 Sep; 52(3):24552.
  • 32
    Faggiano A, Pivonello R, Melis D, Filippella M, Di Somma C, Petretta M, Lombardi G, Colao A. Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure. J Clin Endocrinol Metab. 2003 May; 88(5):207680.
  • 33
    Arrabal-Polo MA, Arrabal-Martin M, de Haro-Muñoz T, Poyatos-Andujar A, Palæo-Yago F, Zuluaga-Gomez A. Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis. Urology. 2012 Jan; 79(1):4854.
  • 34
    Syddall HE, Aihie Sayer A, Dennison EM, Martin HJ, Barker DJP, Cooper C. Cohort profile: the Hertfordshire cohort study. Int J Epidemiol. 2005 Dec; 34(6):123442.
  • 35
    Inskip HM, Godfrey KM, Robinson SM, Law CM, Barker DJ, Cooper C. SWS Study Group. Cohort profile: The Southampton Women's Survey. Int J Epidemiol. 2006 Feb; 35(1):428.